The networks-innovation-firm performance relationship: does it hold good in Indian pharmaceutical industry?

Nirjar, Abhishek; Acharya, Manaswini; Aniruddha, N.A.

doi:10.1504/ijbir.2018.093519

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Umur perusahaan (AGE) yang merupakan variabel kontrol dalam penelitian ini memiliki hubungan yang tidak signifikan terhadap RDI pada seluruh periode. Hasil ini juga searah dengan penelitian lain yang menunjukkan bahwa umur tidak berpengaruh signifikan terhadap RDI (Nirjar et al, 2018;Shefer & Frenkel, 2005). Coad et al, (2016) menjelaskan bahwa hanya perusahaan yang berusia muda (kurang dari 10 tahun) cenderung agresif dalam investasi R&D, sedangkan perusahaan berusia dewasa cenderung enggan melakukan inovasi.…”

Section: Metode Penelitianunclassified

“…Coad et al, (2016) menjelaskan bahwa hanya perusahaan yang berusia muda (kurang dari 10 tahun) cenderung agresif dalam investasi R&D, sedangkan perusahaan berusia dewasa cenderung enggan melakukan inovasi. Nirjar et al, (2018) menjelaskan perusahaan yang berusia lebih tua di India lebih mengandalkan jaringan bisnisnya untuk melakukan inovasi secara eksternal dibandingkan internal sehingga usia tidak berpengaruh signifikan terhadap RDI. Asumsi perusahaan yang dianggap muda beragam di beberapa penelitian, seperti kurang dari 10 tahun (Coad et al, 2016) hingga baru berdiri 2-5 tahun (Falk, 2012).…”

Section: Metode Penelitianunclassified

See 1 more Smart Citation

PERAN TATA KELOLA DAN SUMBER DAYA TERHADAP BEBAN R&D PERUSAHAAN NONKEUANGAN TERBUKA DI INDONESIA

Nathanael¹,

Murhadi²

2022

Eqien

View full text Add to dashboard Cite

To accomplish long-term goals, one of the strategic steps taken by the company is investing in innovation through Research and Development (R&D) spending. Numerous studies show that R&D activities can improve company performance. However, fewer studies discuss the factors involved in R&D investment, especially in Indonesia. In addition, the versatile results of previous studies make this research still relevant. This study aims to determine which factors are involved in R&D expense decisions from a company's resource and corporate governance perspective. This research uses multiple linear regression with the Ordinary Least Square (OLS) estimation method. Based on the stability test, the Covid-19 pandemic affects the relationship between several factors in R&D expense. In all samples, only the proportion of independent commissioners positively affects R&D expenses. There is shifting in the variables of company ownership, profitability, and tangible assets toward R&D expense. But, debt has no significant effect on R&D expenses before and during the pandemic. Thus, ownership concentration, independent commissioner, and company resources, such as tangible assets and other financing sources, have a role in the R&D investment decision. This research shows the crucial role of corporate governance in managing a company's resources to sustain a competitive advantage through R&D activities.

show abstract

Section: Metode Penelitianunclassified

PERAN TATA KELOLA DAN SUMBER DAYA TERHADAP BEBAN R&D PERUSAHAAN NONKEUANGAN TERBUKA DI INDONESIA

Nathanael¹,

Murhadi²

2022

Eqien

View full text Add to dashboard Cite

show abstract

Towards a sustainable energy future: Factors affecting solar-hydrogen energy production in China

Huang¹,

Dai

Xiong

2022

Sustainable Energy Technologies and Assessments

View full text Add to dashboard Cite

Factors affecting the performance of government R&D support programs in pharmaceutical enterprises

Kim,

Kwon,

Kim

et al. 2024

JSTPM

View full text Add to dashboard Cite

Purpose The government support for research and development (R&D) initiatives in the pharmaceutical sector has been declining. The purpose of this study is to analyze factors influencing the efficacy of government R&D support programs directed at pharmaceutical enterprises in South Korea, aiming to provide valuable insights for policymakers responsible for resource allocation in the pharmaceutical industry. Design/methodology/approach The study uses data from 490 R&D projects conducted by 106 pharmaceutical enterprises between 2018 and 2020, sourced from the National Technical Information Service and Drug Approval Research and Technology repositories. The data were analyzed using negative binomial regression analysis operated by the Statistical Package for the Social Sciences. Findings Applied research, cooperative research and the number of doctoral researchers positively impact both the quantitative and qualitative performance of the papers. The number of doctoral researchers, government research funds and the ratio of private investment to total R&D investment positively impacted the quantitative and qualitative performance of patents. However, enterprise age negatively affected patent performance. Notably, sales were significantly associated with patent qualitative performance but not with patent quantitative performance. Originality/value While previous studies have primarily focused on specific types of government R&D support or individual sectors, this study provides a broader perspective by incorporating a variety of variables, to examine the overall performance of government R&D programs in the pharmaceutical sector. This paper addresses the growing concern over declining government support and offers insights that were not fully explored in prior studies. By doing so, this research highlights the importance of understanding how diverse factors collectively influence the effectiveness of government R&D support, providing new directions for innovation and excellence in the pharmaceutical industry.

show abstract

The networks-innovation-firm performance relationship: does it hold good in Indian pharmaceutical industry?

Cited by 3 publications

References 0 publications

PERAN TATA KELOLA DAN SUMBER DAYA TERHADAP BEBAN R&D PERUSAHAAN NONKEUANGAN TERBUKA DI INDONESIA

PERAN TATA KELOLA DAN SUMBER DAYA TERHADAP BEBAN R&D PERUSAHAAN NONKEUANGAN TERBUKA DI INDONESIA

Towards a sustainable energy future: Factors affecting solar-hydrogen energy production in China

Factors affecting the performance of government R&D support programs in pharmaceutical enterprises

Contact Info

Product

Resources

About